🕒 Wednesday 29 April 2026 Wed, 29 Apr 2026

Rokeby Resources bolsters its portfolio with the acquisition of the high-grade Omeo Gold Project in Victoria, while unveiling promising exploration results at its Queensland assets and planning a delayed drilling campaign. The company has secured $4 million in capital commitments and announced key leadership changes.

Emyria Limited is extending its Empax mental health clinic network into New South Wales through a new partnership with Matilda Nepean Private Hospital, increasing treatment capacity and national reach ahead of a planned Q3 2026 launch.

Cosmos Exploration is advancing its Bolivian lithium ambitions by exercising its option to acquire 100% of EAU Lithium and raising A$5 million to fund exploration and acquisition costs.

Resonance Health reports strong cash flow and progress in clinical trials, with a record forward order pipeline for its Software-as-a-Medical-Device business and profitable trial site clinics.

Liontown Limited has kicked off early works and long-lead procurement for its Kathleen Valley lithium expansion, ahead of a Final Investment Decision expected by March 2027.

Axel REE has selected its Woolrich deposit for inaugural in situ recovery (ISR) field trials, backed by metallurgical breakthroughs doubling gallium extraction and confirming scandium co-recovery, positioning Caladão as a rare dual-pathway rare earth project.

HyTerra Ltd is progressing its flagship Nemaha hydrogen project with a key production test planned for Q2 2026, while expanding its global footprint through strategic partnerships and a $7 million capital raise.

Botanix Pharmaceuticals reported a 5% rise in Sofdra prescriptions in Q3 FY26 despite a dip in net revenue due to insurance deductible resets, strengthened by a $45 million capital raise and a new API supply deal with Piramal.

Omega Oil and Gas has secured a commanding acreage position in Queensland’s Taroom Trough and fully funded an expanded drilling program to accelerate appraisal and early production.

Turaco Gold has lifted its Afema Project gold resources by 15% to 4.65 million ounces, driven by multiple deposit upgrades and maiden resource declarations. The Pre-Feasibility Study is on track for Q2 2026, underpinned by a strong cash position and ongoing drilling campaigns.

Redcastle Resources completes a 13,539m grade control drilling program at Redcastle Reef, delivering exceptional high-grade gold intercepts and identifying a 300m western extension. Sixteen new gold targets emerge across the underexplored TBone Belt as mine readiness progresses toward mid-2026 production.

Codan Limited is on track to deliver over 60% growth in EBIT and NPAT for FY26, driven by stronger-than-expected Communications segment revenue and profit margins, alongside robust Minelab performance.

Sky Metals has bolstered its cash reserves with a $20.5 million raise, backing a major drilling push at Tallebung and expanding exploration at Doradilla, positioning both projects for significant resource growth and development progress.

Mont Royal Resources is on track to release an updated Preliminary Economic Assessment for its Ashram Rare Earths project in May, with a promising geological review highlighting the BD-Zone as a key area for resource expansion. The company also secured a strategic non-binding MOU with Saguenay Port Authority and extended funding for critical infrastructure.

Ordell Minerals has reported multiple high-grade gold intersections at its Barimaia project’s McNabs East Prospect, underpinning a 15,000m drilling program planned for May to July 2026 targeting resource growth and new discoveries.

Syrah Resources delivered a record 24kt graphite production at Balama and secured US$72 million in equity to support medium-term ramp-up and Vidalia commercialisation, navigating a complex US trade environment.

Avecho Biotechnology has exceeded its Phase III CBD insomnia trial recruitment target by 16%, setting the stage for a more robust interim analysis scheduled for June 2026. The company’s commercial partnership with Sandoz AG and strengthened patent portfolio underpin its Australian market strategy.

Prospect Resources has delivered further gold assay results from its Nyungu Central deposit, reinforcing the potential for valuable by-product credits at the Mumbezhi Copper Project and setting the stage for an aggressive Phase 3 drilling campaign.

TrivarX appoints Dr Danielle Meyrick as CEO to spearhead clinical trials and commercialisation of its novel stable isotope MRI brain cancer imaging platform, with Phase 1 studies on track for completion this year.

Mamba Exploration has secured a controlling stake in the Meeka East Gold Project, bolstered by a $2 million capital raise and promising early exploration work including extensive soil sampling and historic data validation.

Metal Powder Works has scaled its NextGen powder production to 100 metric tonnes per annum with an industry-leading saleable yield above 95%, setting the stage for an 800MT capacity by 2028 at a fraction of conventional costs.

Nova Eye Medical reported a 23% rise in quarterly sales to US$5.8 million, driven by strong US growth and initial Chinese sales. EBITDA loss narrowed significantly, with positive operational EBITDA recorded.

Sea Forest Limited’s 3Q26 revenue surged 92% to $1.1 million, boosted by expanding SeaFeed™ sales and a pioneering low-carbon wool launch with Theory. New cattle supply deals raise herd commitments to 131,000, underpinning growth amid supportive government policies.

Lotus Resources has completed the first phase of a 10,000m infill drill program at its Letlhakane Uranium Project, revealing significant higher-grade uranium intercepts that underpin a resource upgrade planned for H2 2026.